The TSC1/2 mutations have been noticed in many cancers like pancreatic neuroendocrine, urothelial, bladder, and renal.99–101 Another side of mTOR signaling is to control the cellular growth and metabolism of the cancer cells through enhanced ribosome biogenesis. This evidence concerns the gene TSC1 and cancer.